Checchi Capital Advisers’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.31M Buy
6,558
+531
+9% +$189K 0.12% 123
2025
Q4
$1.97M Buy
6,027
+9
+0.1% +$2.85K 0.1% 125
2025
Q3
$1.7M Sell
6,018
-719
-11% -$209K 0.09% 139
2025
Q2
$1.88M Sell
6,737
-197
-3% -$55.8K 0.11% 130
2025
Q1
$2.16M Buy
6,934
+233
+3% +$68.8K 0.11% 118
2024
Q4
$1.75M Buy
6,701
+44
+0.7% +$13.1K 0.1% 130
2024
Q3
$2.15M Sell
6,657
-184
-3% -$60.2K 0.12% 114
2024
Q2
$2.14M Buy
6,841
+101
+1% +$29.7K 0.11% 108
2024
Q1
$1.92M Sell
6,740
-241
-3% -$70.5K 0.15% 118
2023
Q4
$2.01M Buy
6,981
+99
+1% +$27K 0.16% 110
2023
Q3
$1.85M Sell
6,882
-180
-3% -$44.9K 0.17% 108
2023
Q2
$1.57M Sell
7,062
-167
-2% -$38.8K 0.14% 120
2023
Q1
$1.75M Sell
7,229
-165
-2% -$40.5K 0.17% 113
2022
Q4
$1.94M Sell
7,394
-893
-11% -$239K 0.2% 98
2022
Q3
$1.87M Buy
8,287
+51
+0.6% +$12.4K 0.17% 104
2022
Q2
$2.04M Buy
8,236
+1,274
+18% +$312K 0.18% 97
2022
Q1
$1.68M Buy
6,962
+626
+10% +$144K 0.14% 105
2021
Q4
$1.43M Sell
6,336
-81
-1% -$17.1K 0.13% 121
2021
Q3
$1.36M Sell
6,417
-86
-1% -$19.8K 0.14% 117
2021
Q2
$1.58M Sell
6,503
-335
-5% -$82.4K 0.16% 112
2021
Q1
$1.7M Sell
6,838
-79
-1% -$18.9K 0.17% 100
2020
Q4
$1.59M Sell
6,917
-61
-0.9% -$14.1K 0.16% 106
2020
Q3
$1.77M Sell
6,978
-79
-1% -$19.6K 0.2% 80
2020
Q2
$1.66M Sell
7,057
-297
-4% -$67.8K 0.2% 81
2020
Q1
$1.49M Buy
7,354
+638
+9% +$139K 0.14% 75
2019
Q4
$1.62M Buy
6,716
+320
+5% +$70.5K 0.22% 79
2019
Q3
$1.24M Sell
6,396
-1
-0% -$192 0.16% 88
2019
Q2
$1.18M Sell
6,397
-428
-6% -$76.6K 0.15% 93
2019
Q1
$1.3M Sell
6,825
-230
-3% -$43.9K 0.15% 82
2018
Q4
$1.37M Sell
7,055
-369
-5% -$72K 0.18% 76
2018
Q3
$1.54M Buy
7,424
+941
+15% +$185K 0.18% 79
2018
Q2
$1.2M Buy
6,483
+165
+3% +$29.2K 0.15% 93
2018
Q1
$1.08M Sell
6,318
-1,098
-15% -$202K 0.14% 93
2017
Q4
$1.29M Buy
7,416
+1,039
+16% +$184K 0.17% 82
2017
Q3
$1.19M Sell
6,377
-225
-3% -$39.9K 0.12% 85
2017
Q2
$1.14M Sell
6,602
-1,137
-15% -$185K 0.12% 86
2017
Q1
$1.27M Buy
7,739
+677
+10% +$112K 0.15% 77
2016
Q4
$1.03M Sell
7,062
-383
-5% -$57.6K 0.14% 82
2016
Q3
$1.24M Sell
7,445
-4
-0.1% -$676 0.14% 77
2016
Q2
$1.13M Buy
7,449
+580
+8% +$90.2K 0.13% 78
2016
Q1
$1.03M Sell
6,869
-435
-6% -$64.6K 0.23% 82
2015
Q4
$1.19M Buy
7,304
+904
+14% +$142K 0.3% 71
2015
Q3
$885K Buy
6,400
+213
+3% +$33.6K 0.24% 80
2015
Q2
$950K Sell
6,187
-636
-9% -$102K 0.25% 76
2015
Q1
$1.09M Buy
6,823
+539
+9% +$84.9K 0.32% 66
2014
Q4
$1M Buy
6,284
+803
+15% +$125K 0.38% 61
2014
Q3
$770K Buy
5,481
+1,753
+47% +$229K 0.32% 66
2014
Q2
$441K Buy
3,728
+752
+25% +$87.1K 0.2% 94
2014
Q1
$367K Buy
2,976
+563
+23% +$68.3K 0.23% 87
2013
Q4
$275K Buy
+2,413
New +$274K 0.21% 97

Other funds holding AMGN

Checchi Capital Advisers's AMGN Position: Q1 2026 in Review

Checchi Capital Advisers increased its Amgen (AMGN) stake by 8.8% in Q1 2026, buying an estimated $189K and bringing the position to 6,558 shares worth $2.31M. The position accounts for 0.12% of the portfolio, ranked #123.

Checchi Capital Advisers first reported a position in AMGN in Q4 2013 and has held it in 50 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Checchi Capital Advisers held 6,558 shares of Amgen worth $2.31M as of Q1 2026.
  • Checchi Capital Advisers bought 531 Amgen shares in Q1 2026, an estimated $189K.
  • Amgen made up 0.12% of Checchi Capital Advisers's portfolio in Q1 2026, its #123 holding.
  • Checchi Capital Advisers first reported a position in Amgen in Q4 2013 and has held it in 50 quarters since.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Checchi Capital Advisers's 13F filing for Q1 2026, filed 4 May 2026.